Potratz J - Search Results

1

Gene Expression Profiling of Ewing Sarcoma Tumors Reveals the Prognostic Importance of Tumor-Stromal Interactions: A Report from the Children's Oncology Group.

Volchenboum SL, Andrade J, Huang L, Barkauskas DA, Krailo M, Womer RB, Ranft A, Potratz J, Dirksen U, Triche TJ, Lawlor ER. Volchenboum SL, et al. Among authors: potratz j. J Pathol Clin Res. 2015 Apr;1(2):83-94. doi: 10.1002/cjp2.9. J Pathol Clin Res. 2015. PMID: 26052443 Free PMC article.

2

Ewing sarcoma: clinical state-of-the-art.

Potratz J, Dirksen U, Jürgens H, Craft A. Potratz J, et al. Pediatr Hematol Oncol. 2012 Feb;29(1):1-11. doi: 10.3109/08880018.2011.622034. Pediatr Hematol Oncol. 2012. PMID: 22295994 Review.

3

Development of curative therapies for Ewing sarcomas by interdisciplinary cooperative groups in Europe.

Bölling T, Braun-Munzinger G, Burdach S, Calaminus G, Craft A, Delattre O, Deley MC, Dirksen U, Dockhorn-Dworniczak B, Dunst J, Engel S, Faldum A, Fröhlich B, Gadner H, Göbel U, Gosheger G, Hardes J, Hawkins DS, Hjorth L, Hoffmann C, Kovar H, Kruseova J, Ladenstein R, Leuschner I, Lewis IJ, Oberlin O, Paulussen M, Potratz J, Ranft A, Rössig C, Rübe C, Sauer R, Schober O, Schuck A, Timmermann B, Tirode F, van den Berg H, van Valen F, Vieth V, Willich N, Winkelmann W, Whelan J, Womer RB. Bölling T, et al. Among authors: potratz j. Klin Padiatr. 2015 May;227(3):108-15. doi: 10.1055/s-0035-1545263. Epub 2015 May 18. Klin Padiatr. 2015. PMID: 25985445

4

Ewing sarcoma: biology-based therapeutic perspectives.

Potratz J, Jürgens H, Craft A, Dirksen U. Potratz J, et al. Pediatr Hematol Oncol. 2012 Feb;29(1):12-27. doi: 10.3109/08880018.2011.627582. Pediatr Hematol Oncol. 2012. PMID: 22304007 Review.

5

Suberoylanilide hydroxamic acid synergistically enhances the antitumor activity of etoposide in Ewing sarcoma cell lines.

Unland R, Clemens D, Heinicke U, Potratz JC, Hotfilder M, Fulda S, Wardelmann E, Frühwald MC, Dirksen U. Unland R, et al. Anticancer Drugs. 2015 Sep;26(8):843-51. doi: 10.1097/CAD.0000000000000256. Anticancer Drugs. 2015. PMID: 26053276

6

Anchorage-independent growth of Ewing sarcoma cells under serum-free conditions is not associated with stem-cell like phenotype and function.

Leuchte K, Altvater B, Hoffschlag S, Potratz J, Meltzer J, Clemens D, Luecke A, Hardes J, Dirksen U, Juergens H, Kailayangiri S, Rossig C. Leuchte K, et al. Among authors: potratz j. Oncol Rep. 2014 Aug;32(2):845-52. doi: 10.3892/or.2014.3269. Epub 2014 Jun 13. Oncol Rep. 2014. PMID: 24927333

7

The CXCR4 antagonist plerixafor (AMD3100) promotes proliferation of Ewing sarcoma cell lines in vitro and activates receptor tyrosine kinase signaling.

Berning P, Schaefer C, Clemens D, Korsching E, Dirksen U, Potratz J. Berning P, et al. Among authors: potratz j. Cell Commun Signal. 2018 May 18;16(1):21. doi: 10.1186/s12964-018-0233-2. Cell Commun Signal. 2018. PMID: 29776413 Free PMC article.

8

The first European interdisciplinary ewing sarcoma research summit.

Kovar H, Alonso J, Aman P, Aryee DN, Ban J, Burchill SA, Burdach S, De Alava E, Delattre O, Dirksen U, Fourtouna A, Fulda S, Helman LJ, Herrero-Martin D, Hogendoorn PC, Kontny U, Lawlor ER, Lessnick SL, Llombart-Bosch A, Metzler M, Moriggl R, Niedan S, Potratz J, Redini F, Richter GH, Riedmann LT, Rossig C, Schäfer BW, Schwentner R, Scotlandi K, Sorensen PH, Staege MS, Tirode F, Toretsky J, Ventura S, Eggert A, Ladenstein R. Kovar H, et al. Among authors: potratz j. Front Oncol. 2012 May 29;2:54. doi: 10.3389/fonc.2012.00054. eCollection 2012. Front Oncol. 2012. PMID: 22662320 Free PMC article.

9

Receptor tyrosine kinase gene expression profiles of Ewing sarcomas reveal ROR1 as a potential therapeutic target in metastatic disease.

Potratz J, Tillmanns A, Berning P, Korsching E, Schaefer C, Lechtape B, Schleithoff C, Unland R, Schäfer KL, Müller-Tidow C, Jürgens H, Dirksen U. Potratz J, et al. Mol Oncol. 2016 May;10(5):677-92. doi: 10.1016/j.molonc.2015.12.009. Epub 2015 Dec 20. Mol Oncol. 2016. PMID: 26739507 Free PMC article.

10

The Receptor Tyrosine Kinase RON and Its Isoforms as Therapeutic Targets in Ewing Sarcoma.

Berning P, Hennemann C, Tulotta C, Schaefer C, Lechtape B, Hotfilder M, El Gourari Y, Jürgens H, Snaar-Jagalska E, Hempel G, Dirksen U, Potratz J. Berning P, et al. Among authors: potratz j. Cancers (Basel). 2020 Apr 7;12(4):904. doi: 10.3390/cancers12040904. Cancers (Basel). 2020. PMID: 32272784 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

83 results

Search Page